HEALTHCARE
Hims & Hers shares rise as company adds new weight-loss medications to platform
The Hims app arranged on a smartphone in New York on Feb. 12, 2025.Gabby Jones | Bloomberg | Getty ImagesHims & Hers Health...
HEALTHCARE
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes...
Subscribe
– Stay updated in real-time
– Get in-depth insights and trends
– News straight to your inbox
Must read